BREAKING NEWS: MHRA Contraception Alert for Patients on Mounjaro or Wegovy
Women taking weight loss injections must use effective contraception, according to new guidance issued on June 5 2025, by the UK’s medicines regulator, The Medicines and Healthcare products Regulatory Agency (MHRA).
Learn more about common treatments
Picture showing MHRA-approved Wegovy – Mounjaro
Key Takeaways
Contraception Required During Use
Women of childbearing potential must use effective contraception while taking Mounjaro or Wegovy.
These medicines must not be taken:
- During pregnancy
- While actively trying to become pregnant
- During breastfeeding
Stop Treatment If Pregnant or Breastfeeding
If you become pregnant while using either medicine, then you should stop the treatment immediately.
This is due to a lack of sufficient safety data on the use of these medications during pregnancy, and the potential for harm to the fetus is unknown.
Wait Before Trying to Conceive
In some cases, the MHRA recommends that contraception be continued for up to two months after stopping the medication before attempting pregnancy.
This ensures the drug is fully cleared from the body.
What the MHRA guidance is advising patients on Wegovy or Mounjaro
The MHRA warned that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Mounjaro (tirzepatide) and Wegovy (Semaglutide), should not be taken during:
- pregnancy
- while trying to conceive
- during breastfeeding
The regulator advised anyone who becomes pregnant while using these medications to stop immediately, citing insufficient safety data to determine if they could harm the baby.
In some cases, contraception should continue for up to two months after stopping the medication before attempting to conceive.
Additional Concerns
Additional concerns were raised about the effectiveness of oral contraceptives in patients taking tirzepatide-based drugs like Mounjaro. According to the MHRA, Mounjaro may reduce the effectiveness of oral contraception in individuals who are overweight.
As a precaution, patients in this category are advised to use a non-oral form of contraception alongside their current method, particularly during the first four weeks of starting Mounjaro or after any dose increases.
The guidance follows growing concerns that some individuals may not be using these medications safely, especially outside their intended purpose of managing weight-related conditions and type 2 diabetes. The agency emphasized that the guidance reinforces information already included in patient leaflets and is intended as a reminder of best practices for safe use.
Other Risks Highlighted
The MHRA also highlighted the risk of acute pancreatitis, a rare but serious side effect of GLP-1 drugs. Patients are urged to be aware of symptoms such as severe stomach pain that radiates to the back and persists. Immediate medical attention is advised if such symptoms occur.
In a strong warning against the purchase of these medicines from unregulated sources, the regulator stressed that GLP-1 medications should only be obtained from legitimate pharmacies. Buying from beauty salons or through social media poses a risk of receiving counterfeit or unsafe products.
MHRA chief safety officer Dr. Alison Cave emphasized that these medications are approved for specific medical conditions and should not be used for aesthetic or cosmetic purposes. She warned that they are not a quick fix for weight loss and have not been proven safe when used outside of their licensed indications.
Final Thoughts
The guidance is intended as a central resource for patients seeking reliable information on the safe use of GLP-1 medicines, but should not replace the patient information leaflet or consultations with healthcare professionals during the prescribing process.
The UK’s National Pharmacy Association (NPA), urged both pharmacists and patients to take note of the updated MHRA advice. They reported that community pharmacies are experiencing unprecedented demand for weight loss injections and encouraged patients with concerns to seek guidance from their pharmacist.
The MHRA’s announcement comes amid rising concern over adverse events related to these drugs.
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Related Articles
Can I Trust NowPatient
Our product and services are certified to international healthcare, medical device and data security standards
Medicines Experts
Meet our medical team
We are a broad skilled and passionate group of clinicians with experience of operating in health systems in the United Kingdom & United States. Providing excellent care and advice is at the heart of everything we do. You can read more about our medical team by visiting the medical team page or learn more about how we curate content by visiting our editorial process
WHY WE BUILT NOWPATIENT
We are committed to helping everyone, everywhere live healthier lives
The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Your Questions Answered
For your peace of mind, we can answer your questions quickly
What does NowPatient do?
NowPatient is a digital health-technology platform functioning as both an online pharmacy and telehealth service. Packaged as a Class I software medical device, it’s accessible via web browser or mobile app (iOS and Android), and offers users worldwide on-demand access to virtual consultations, prescription services, and AI-powered health tools.
What It Does
-
- NHS Online Pharmacy: Order NHS-approved prescriptions (UK)
- Drug Savings: Access major US drug-savings programs (coupons, savings cards, manufacturer assistance, Canadian drug savings).
- Virtual Consultations: Get treated for a wide range of medical conditions by expert clinicians using a secure telehealth link.
- Medication Management: Set up refill & dose reminders, view private treatment plans, and track chronic conditions like diabetes or hypertension.
- Health-Monitoring Tools: Use AI-driven assessments for genetic risk tests, home test kits and blood-pressure monitoring.
- Wellness Insights: Access real-time pollen counts, air-quality data, BMI and type 2 diabetes risk scores, plus comprehensive health-condition information.
Get started today and benefit from Medication Reminders, Get Treated Privately, NHS Online Pharmacy, GP Appointment Booking, Rx Savings Card, Drug Coupons, US Drug Savings Programs, Health Conditions Information, Genetic Testing, Home Test Kits, BMI Risks, Type 2 Diabetes Risks, Pollen Meter, Air Quality Monitor, and lots more!
Our service is operated by experienced medical professionals in the United States and the United Kingdom.
You can view the online services we provide by clicking the link below:
Where is NowPatient located?
NowPatient has offices in the United Kingdom and United States.
In the UK, we are located at:
NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA
In the US, we are located at:
NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX
How can I contact NowPatient?
To contact NowPatient, please use the contact form available on the Contact Us page.
Alternatively, if you need to speak to us, you can reach us on the following numbers:
UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977
Who owns NowPatient?
NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.
Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).
Can you tell me more about your NHS online pharmacy?
NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.
Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).
Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.
How do I make a complaint?
From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.
Can you tell me more about NowPatient’s prescribing services for treatments offered?
Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:
• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old
NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.
Can you tell me more about NowPatient’s US services?
Our head of US services is Dr. Jamie Winn.
You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.
Is NowPatient legit and can I trust information from NowPatient?
Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.
NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.
Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:
What are NowPatient’s opening hours?
Our office hours are:
UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST
Please note that we are closed at weekends.
In the event of a medical life-threatening emergency please call:
UK – 999
US – 911
In the event of a medical emergency which is not life-threatening please call:
UK – 111